磁性壳聚糖硅胶复合微球的制备及其吸附Cu~(2+)的性能研究

以壳聚糖与正硅酸四乙酯为原料,采用溶胶-凝胶法,用戊二醛辅助交联合成了磁性壳聚糖硅胶复合微球。通过红外光谱、扫描电镜、X-射线衍射等方法对磁性壳聚糖硅胶复合微球的形态和组成特性进行分析,制备的磁性复合微球中壳聚糖与硅胶材料复合均匀,材料粒径均一,机械强度较高。考察了制备的磁性壳聚糖硅胶复合微球对Cu~(2+)的吸附性能,结果表明微球对Cu~(2+)具有较好的吸附性能,吸附容量达到98.7mg/g。     

离子凝聚法制备负载流感疫苗的壳聚糖微球

采用三聚磷酸钠(TPP)作为离子交联剂, 应用离子凝聚法制备负载流感疫苗的壳聚糖微球. 筛选出壳聚糖起始质量分数为1%. TPP的浓度对壳聚糖微球的制备影响较大, 采用低浓度的TPP(200 μg/mL)制备的微球放置过夜均出现沉淀现象, 高浓度的TPP(800 μg/mL)在制备过程中出现絮状沉淀. 固化比影响微球的释放行为, 固化比为1∶1的微球爆炸式释放率达到90％, 固化比为1∶3的微球6 h后逐步释放, 12 h后释放率达到95％. 固化比为1∶5的微球6 h后没有明显的释放行为. 壳聚糖溶液的pH对微球的制备和释放没有显著的影响. 通过对负载流感疫苗的壳聚糖微球的制备条件和释放行为的研究结果表明, pH=5.6的壳聚糖溶液, 固化比为1∶3, TPP的质量浓度为400 μg/mL是较理想的流感疫苗壳聚糖微球的制备条件.     

反相非水乳液制备多孔聚酰亚胺微球

在Span85/N,N-二甲基甲酰胺/液体石蜡稳定反相非水乳液体系中,以均苯四甲酸酐和4,4’-二氨基二苯醚为单体,选用甲醇、二硫化碳作为致孔剂,制备多孔聚酰亚胺(PI)微球.通过SEM、量子化学模拟、粒径测试等手段考察致孔剂种类、致孔剂用量、吡啶/酸酐滴加速度及反应温度和单体浓度对致孔的影响.结果表明,选用二硫化碳、甲醇为致孔剂时所制得的微球形貌良好,但CS2为致孔剂时,所得到的微球孔道很少;而甲醇为致孔剂时,则得到了孔道明显的多孔PI微球.致孔的最佳条件为反应温度20℃,单体浓度10%,吡啶/酸酐滴加速度0.5 s/滴时,才可得到的形貌良好、分布均一的多孔PI微球.而且随着甲醇/液体石蜡的体积比增加,多孔PI微球比表面积也随着增大,最大可达29.38 m2/g.所得产物粒径分布在20~30μm之间,热稳定性良好,其起始热分解温度为517℃.     

高强度聚乙烯醇水凝胶微球的制备

以三氯甲烷/丙酮为凝固液, 用高压静电技术制备了高强度、物理交联的聚乙烯醇(PVA)水凝胶微球. 研究了凝固液组成、PVA溶液浓度、温度和湿度、电场强度、进样速度及微球冷冻次数等对PVA微球的形貌、粒径和强度的影响. 结果表明, 采用常压水蒸气控制PVA溶液温度与湿度的高压静电技术, 可克服高浓度PVA溶液在强电场下出现微丝现象, 形成的水凝胶微球具有强度高、粒径在一定范围内可控的特点.     

静电喷雾法制备聚膦腈微球

用静电喷雾法制备了粒径窄分布的甘氨酸乙酯-苯丙氨酸乙酯取代聚膦腈的微球.主要探讨了溶剂、溶液浓度、流速、喷射电压及接收距离对微球形貌和粒径的影响.微球的表面形貌与溶剂性质和聚合物溶液浓度密切相关,微球粒径受聚合物溶液流速的影响比较显著,随流速增大粒径呈单调上升趋势.结果显示对于[η]=0.1 dL/g的(甘氨酸乙酯)0.3(苯丙氨酸乙酯)0.7取代聚膦腈,以0.25 g/mL的四氢呋喃溶液进行静电喷雾,可获得粒径分布窄(1~2μm)且近球形的微粒,其工艺条件可进一步用于载药聚膦腈微球的制备和控制释放研究.     

醇热法制备钛胶色谱固定相及其性质研究

以钛酸四丁酯为原料,采用醇热法制备了氧化钛微球色谱填料,制备方法简便,条件易于控制。借助扫描电镜、X-粉末衍射、氮吸附法等手段研究了其表面物理化学性质,表明所制多孔微球粒径均匀(5μm~7μm),孔径在中孔范围内(7.4 nm),平均孔体积(0.31 cm3.g-1),比表面积大(116.6 m2.g-1),孔径分布较窄,性质较其它常用方法都有较大提高;电位滴定结果显示微球表面酸性弱于常规硅胶。将其用于分离中性和碱性化合物时,显示出较好的色谱性能。     

单分散聚苯乙烯微球的制备及表征

应用膜乳化-液中干燥法成功制备出粒径为2～20μm的单分散聚苯乙烯(PS)微球.PS微球的粒径主要由膜孔径决定,其值约为膜孔径的2倍;PS溶液的浓度对其也有一定的影响.膜乳化过程中的压力对微球粒径的分散性有很大的影响,在一定压力范围内,粒径呈单分散.在分散相中加入致孔剂,制备出表面多孔的PS微球.采用复乳-液中干燥法制备出中空PS微球.     

作为细胞微载体的明胶基缓释微球的制备

用改良的乳化冷凝法制备载牛血清蛋白(BSA)的大粒径明胶微球. 结果表明, 明胶水溶液的质量分数为25%、水相与油相体积比3∶20、搅拌速度300 r/min、交联剂用0.1 mL质量分数为25%的戊二醛、 表面活性剂用0.1 g span-80为制备平均直径约250 μm明胶微球的理想条件. 所制备微球的后处理方法不同, 则明胶微球的表面形貌也不同, 细胞粘附率不同. 空白明胶微球在体外可以完全降解, 载BSA的明胶微球对BSA具有良好的缓释性, 释放时间可长达30 d. 显微镜观察成纤维细胞在明胶微载体上生长良好.     

一步聚合法制备壳核型、可控阶层结构的羰基铁/聚苯乙烯复合微球

采用改进的悬浮聚合法合成了一系列粒径和结构可调的羰基铁粉/聚苯乙烯磁性高分子微球.利用傅立叶变换红外光谱仪、热重分析仪、X射线衍射仪、扫描电镜等分析了微球的结构、化学成分及形貌.结果表明,通过改变苯乙烯单体和聚乙烯醇(PVA)的加入量,可以制备三类不同形貌和结构的复合微球,即多孔复合微球,无孔复合微球和含"带状"突起的...     

磁性壳聚糖微球用于脲激酶的固定化研究I. 磁性壳聚糖微球的制备和表征

为制备用于固定化酶的磁性壳聚糖微球,本文首先用化学共沉淀法制备了磁流体,随后在磁流体存在下进行壳聚糖和戊二醛的共聚反应。结果表明,磁流体中的Ｆｅ３Ｏ４以水化物的状态存在,其含量为２．０４％,平均粒径为０．２～０．５ｕｍ左右;磁性壳聚糖微球的弱碱交换量随交联度的增加而减小,质量磁化率与微球粒径成反比。该微球具有良好的磁响应性,在外加磁场下可被快速的从溶液中分离出来。     

离子凝胶反应法制备壳聚糖/N,O-羧甲基壳聚糖微球

以一氯乙酸与壳聚糖反应形成N,O-羧甲基壳聚糖两性聚电解质,分光光度法测定其等电点IEP=2．86。以此两性聚电解质与壳聚糖可以在一定条件下形成微球,光学显微镜和电子显微镜测试表明,控制两种聚电解质配比可以制备不同粒径大小的微球,而超声功率对微球粒径的影响较小。红外光谱测试表明微球中N,O-羧甲基壳聚糖羧基以羧酸根形式存在,分光光度与电导法联合测定表明两种聚电解质以离子凝胶作用形成微球,其最佳制备条件为IEP（CM-CHITOSAN）〈pH〈pKa（CS）,在此较宽的pH值范围内微球可稳定存在。     

Preparation of uniform-sized pH-sensitive quaternized chitosan microsphere by combining membrane emulsification technique and thermal-gelation method

In this study, uniform-sized pH-sensitive quaternized chitosan microsphere was prepared by combining Shirasu porous glass (SPG) membrane emulsification technique and a novel thermal-gelation method. In this preparation process, the mixture of quaternized chitosan solution and alpha-beta-glycerophosphate (alpha-beta-GP) was used as water phase and dispersed in oil phase to form uniform W/O emulsion by SPG membrane emulsification technique. The droplets solidified into microspheres at 37 degrees C by thermal-gelation method. The whole process was simple and mild. The influence of process conditions on the property of prepared microspheres was investigated and the optimized preparation condition was obtained. As a result, the coefficient of variation (C.V.) of obtained microspheres diameters was below 15%. The obtained microsphere had porous structure and showed apparent pH-sensitivity. It dissolved rapidly in acid solution (pH 5) and kept stable in neutral solution (pH 7.4). The pH-sensitivity of microspheres also affected its drug release behavior. Bovine serum albumin (BSA) as a model drug was encapsulated in microspheres, and it was released rapidly in acid solution and slowly in neutral medium. The novel quaternized chitosan microspheres with pH-sensitivity can be used as drug delivery system in the biomedical field, such as tumor-targeted drug carrier.     

Chitosan based hydrogel microspheres as drug carriers

Chitosan/tripolyphosphate (CHIT/TPP) and chitosan/tripolyphosphate/chondroitin sulfate (CHIT/TPP/CHS) core-shell type microspheres were prepared by polyelectrolyte complexation in order to develop a biocompatible matrix for drug delivery. The continual method using a multi-loop reactor under sterile conditions was applied for microsphere preparation. All the types of microspheres produced were spherical in shape and had a porous structure. The mechanical resistance of the microspheres increased in the presence of CHS as the second polyanion, which toughened the microsphere shell structure. For a drug release application, the process of microsphere preparation was modified by dissolving ofloxacin (OFL), the fluoroquinolone antibiotic, in CHIT solution before complex formation. This study shows the difference in OFL release comparing the microspheres CHIT/TPP and CHIT/TPP/CHS and implies the potential to control this process.     

W/O乳化法制备明胶/β-磷酸三钙多孔复合微球及其热学性能

采用乳液、离子缔合法制备得到明胶(Gel)/β-纳米磷酸三钙(β-TCP)复合多孔微球,其尺寸可通过控制反应的搅拌速度进行调节. SEM和光学显微镜观察表明,明胶/β-TCP复合微球尺寸在20～40 μm之间,被包敷的磷酸三钙为200 nm左右,微球内部呈多孔结构. 当m(磷酸三钙)∶m(明胶)＞0.4∶1时,有大量花瓣状晶体附着于复合微球的表面,是磷酸三钙溶解和明胶分子诱导重结晶所致. XRD与IR图谱表明,磷酸三钙纳米粒子与明胶之间存在化学键合,明胶/β-纳米磷酸三钙复合微球的微观结构与自然骨相似. DSC-TGA结果显示,90%的TCP在乳化过程中与明胶复合. 本文所制备的复合微球,为添加各种药物和促骨生长因子并实现缓释提供了优良的载体.     

内部结构不对称磁性复合微球的制备及其影响因素探究

内部结构不对称复合微球是指无机粒子在复合微球内部呈现规律性、不对称分布的一类微球.采用细乳液聚合的方法一步合成了平均粒径0.8μm、磁含量为46.67%、比饱和磁化强度为23.20 emu/g的内部结构不对称PSt/Fe3O4磁性复合微球.详细考察了Fe3O4纳米粒子表面修饰剂含量、乳化剂、助乳化剂、超分散剂、细乳化时间等因素对于复合微球形貌的影响,探讨了内部结构不对称复合微球的形成机理.同时通过TEM(透射电子显微镜),FTIR(红外光谱),VSM(振动样品磁强计),TG(热失重分析)以及激光粒度仪等表征手段对微球内部形貌、磁化强度及粒径等进行了表征,确定Fe3O4纳米粒子表面性质是微球呈现内部结构不对称的决定性因素.     

Control of heterogeneous structure of porous polymer microspheres prepared from polymerization system and preformed polymer system

The studies on control of heterogeneous structure of porous polymer microspheres prepared for suspension polymerization system and preformed polymer system in author’s research group were reviewed. Firstly, the phase-separation behavior in O/W suspension polymerization system for preparation of porous poly(divinylbenzene) microspheres was quantitatively studied by combining transmittance and gelation point measurement, from which the morphology can be manipulated. The same method can be employed to study the pore size control in W/O hydrophilic polymerization system. Because the simple porous microsphere could not satisfy new applications, we developed new methods to prepare gigaporous microsphere, which possessed much larger pores than those obtained by general diluents, for chromatographic separation media, as well as hollow-porous microsphere for construction of cell-like microreactor. Furthermore, in order to overcome the difficulty of heterogeneous structure control for preformed polymer system, we developed special methods to obtain porous, hollow-porous, and hollow chitosan microspheres. Finally, some application results by utilizing special morphologies were introduced.     

磁性壳聚糖微球的制备及对Cr(Ⅵ)的吸附性能研究

用壳聚糖包埋磁流体,用戊二醛交联制成磁性壳聚糖微球,并用红外光谱表征其结构。用制备的磁性壳聚糖微球吸附Cr(Ⅵ)离子,考察了其对Cr(Ⅵ)离子的吸附性能;探讨了吸附时间、溶液pH值、吸附剂用量、温度、Cr(Ⅵ)起始浓度以及其他离子存在对Cr(Ⅵ)离子去除率的影响。实验结果表明,磁性壳聚糖微球吸附Cr(Ⅵ)离子的最佳条件为:吸附平衡时间40 min,最佳吸附pH值6左右,磁性壳聚糖微球用量10 mg,温度升高有利于提高磁性壳聚糖微球的吸附效率,Cr(Ⅵ)离子起始质量浓度为12μg/mL,无机盐的存在引起磁性壳聚糖微球的吸附性能降低。并且考察了吸附剂的再生性能,实验结果表明磁性壳聚糖微球具有良好的重复使用性。     

Preparation of Porous Polylactide Microspheres and Their Application in Tissue Engineering

In this study,porous polylactide (PLA) microspheres with different structures were prepared through the multiple emulsion solvent evaporation method.By changing organic solvents (ethyl acetate and chloroform) and adding effervescent salt NH4HCO3 in the inner water phase,microspheres with porous capsular,matrix,microcapsular and multivesicular structures were prepared.The protein encapsulation and release,and the cell growth behavior of porous microspheres were further explored.Under the same inner water phase,microspheres prepared with chloroform had higher protein encapsulation efficiency and less protein release rate as compared with those prepared with ethyl acetate.Cell experiments showed that the relatively rough surface of microspheres prepared with chloroform was more favorable for the cell growth in comparison with the smooth surface of microspheres prepared with ethyl acetate.This study shows a simple and effective method to control the protein release and cell growth behaviors of polymer microspheres by tuning their porous structure.     

香草醛交联壳聚糖载药微球的性能及其成球机理分析

以壳聚糖溶液为水相、液体石蜡为油相形成油包水型乳液, 以香草醛为交联剂, 采用乳化交联法制得壳聚糖微球. 结合IR光谱和XRD测试, 分析了壳聚糖交联固化成球的机理: 壳聚糖和香草醛之间所发生的Schiff碱反应和氢键的形成以及缩醛化反应, 以此为基础共同形成交联结构从而使壳聚糖交联固化成球. 探讨了交联后壳聚糖微球结晶度降低的原因: 壳聚糖固化时分子链未充分进行有序的结晶排列, 交联后的壳聚糖结构较复杂, 从而破坏了原壳聚糖分子的规整性. 选用盐酸小檗碱为模型药物, 制备了香草醛交联的壳聚糖载药微球, SEM结果显示, 载药微球表面致密且球形度好, 微球粒径在5-15 μm之间. 此外, 采用分光光度计对载药微球的载药率、药物包封率和药物体外释放性质进行了测试和分析, 结果表明载药微球缓释效果明显.